99 related articles for article (PubMed ID: 25005449)
1. Genetic background-dependent thrombotic microangiopathy is related to vascular endothelial growth factor receptor 2 signaling during anti-glomerular basement membrane glomerulonephritis in mice.
Mesnard L; Cathelin D; Vandermeersch S; Rafat C; Luque Y; Sohier J; Nochy D; Garcon L; Callard P; Jouanneau C; Verpont MC; Tharaux PL; Hertig A; Rondeau E
Am J Pathol; 2014 Sep; 184(9):2438-49. PubMed ID: 25005449
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis.
Yuan HT; Tipping PG; Li XZ; Long DA; Woolf AS
Kidney Int; 2002 Jun; 61(6):2078-89. PubMed ID: 12028448
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis.
Shimizu A; Masuda Y; Mori T; Kitamura H; Ishizaki M; Sugisaki Y; Fukuda Y
J Am Soc Nephrol; 2004 Oct; 15(10):2655-65. PubMed ID: 15466270
[TBL] [Abstract][Full Text] [Related]
4. Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis.
Heeringa P; van Goor H; Itoh-Lindstrom Y; Maeda N; Falk RJ; Assmann KJ; Kallenberg CG; Jennette JC
Am J Pathol; 2000 Mar; 156(3):879-88. PubMed ID: 10702405
[TBL] [Abstract][Full Text] [Related]
5. Resistance of CD28-deficient mice to autologous phase of anti-glomerular basement membrane glomerulonephritis.
Nitta K; Horita S; Ogawa S; Matsumoto M; Hara Y; Okano K; Hayashi T; Abe R; Nihei H
Clin Exp Nephrol; 2003 Jun; 7(2):104-12. PubMed ID: 14586728
[TBL] [Abstract][Full Text] [Related]
6. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.
Fujita E; Nagahama K; Shimizu A; Aoki M; Higo S; Yasuda F; Mii A; Fukui M; Kaneko T; Tsuruoka S
J Nippon Med Sch; 2015; 82(1):27-35. PubMed ID: 25797872
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of anti-GBM disease with thrombotic microangiopathy: a case report and literature review.
Nakamura Y; Kato N; Tatematsu Y; Arai Y; Mori N; Shibata K; Yamazaki M; Yasui H; Fujiwara S; Yamakawa T; Maruyama S
CEN Case Rep; 2024 Feb; 13(1):37-44. PubMed ID: 37213063
[TBL] [Abstract][Full Text] [Related]
8. SMAD3-dependent and -independent pathways in glomerular injury associated with experimental glomerulonephritis.
Ghayur A; Padwal MK; Liu L; Zhang J; Margetts PJ
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F152-F162. PubMed ID: 31141397
[TBL] [Abstract][Full Text] [Related]
9. VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience.
Ozawa M; Ohtani H; Komatsuda A; Wakui H; Takahashi N
Clin Exp Nephrol; 2021 Nov; 25(11):1193-1202. PubMed ID: 34115234
[TBL] [Abstract][Full Text] [Related]
10. Anti-glomerular Basement Membrane Disease with Atypical Associations.
Malviya PB; Modigonda S; Maitra S; Gowrishankar S
Saudi J Kidney Dis Transpl; 2021; 32(1):227-231. PubMed ID: 34145136
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of anti-GBM glomerulonephritis model: the role of NF-kappaB in immune complex kidney disease.
Kim JH; Ha IS; Hwang CI; Lee YJ; Kim J; Yang SH; Kim YS; Cao YA; Choi S; Park WY
Kidney Int; 2004 Nov; 66(5):1826-37. PubMed ID: 15496153
[TBL] [Abstract][Full Text] [Related]
12. ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy.
Erpenbeck L; Demers M; Zsengellér ZK; Gallant M; Cifuni SM; Stillman IE; Karumanchi SA; Wagner DD
J Am Soc Nephrol; 2016 Jan; 27(1):120-31. PubMed ID: 26038528
[TBL] [Abstract][Full Text] [Related]
13. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis.
Hochegger K; Siebenhaar F; Vielhauer V; Heininger D; Mayadas TN; Mayer G; Maurer M; Rosenkranz AR
Eur J Immunol; 2005 Oct; 35(10):3074-82. PubMed ID: 16180252
[TBL] [Abstract][Full Text] [Related]
14. Seronegative Atypical Anti-Glomerular Basement Membrane Glomerulonephritis Associated With Thrombotic Microangiopathy: Case Report and Literature Analysis.
Roy S; Hou J; Chourasia P; Yalamanchili A; Basuli D; Errabelli PK; Sai Yarram S; Ayala R; Adapa S
J Investig Med High Impact Case Rep; 2023; 11():23247096231184760. PubMed ID: 37421300
[TBL] [Abstract][Full Text] [Related]
15. Renal thrombotic microangiopathy in mice with combined deletion of endocytic recycling regulators EHD3 and EHD4.
George M; Rainey MA; Naramura M; Foster KW; Holzapfel MS; Willoughby LL; Ying G; Goswami RM; Gurumurthy CB; Band V; Satchell SC; Band H
PLoS One; 2011 Mar; 6(3):e17838. PubMed ID: 21408024
[TBL] [Abstract][Full Text] [Related]
16. Removal of elevated circulating angiopoietin-2 by plasma exchange--a pilot study in critically ill patients with thrombotic microangiopathy and anti-glomerular basement membrane disease.
Lovric S; Lukasz A; Hafer C; Kielstein JT; Haubitz M; Haller H; Kümpers P
Thromb Haemost; 2010 Nov; 104(5):1038-43. PubMed ID: 20806109
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis.
Câmpean V; Karpe B; Haas C; Atalla A; Peters H; Rupprecht H; Liebner S; Acker T; Plate K; Amann K
Am J Physiol Renal Physiol; 2008 May; 294(5):F1174-84. PubMed ID: 18272601
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.
Izzedine H; Mangier M; Ory V; Zhang SY; Sendeyo K; Bouachi K; Audard V; Péchoux C; Soria JC; Massard C; Bahleda R; Bourry E; Khayat D; Baumelou A; Lang P; Ollero M; Pawlak A; Sahali D
Kidney Int; 2014 Feb; 85(2):457-70. PubMed ID: 24067439
[TBL] [Abstract][Full Text] [Related]
19. Association of vascular endothelial growth factor and renal thrombotic microangiopathy-like lesions in patients with Castleman's disease.
Sun PP; Yu XJ; Wang SX; Zhou XJ; Qu L; Zhang F; Ma YY; Liu G; Yang L
Nephrology (Carlton); 2020 Feb; 25(2):125-134. PubMed ID: 31264312
[TBL] [Abstract][Full Text] [Related]
20. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
Keller K; Daniel C; Schöcklmann H; Endlich KH; Kerjaschki D; Johnson RJ; Hugo C
Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
